10
Economic Research Service/USDA
An Economic Assessment of Food Safety Regulations
proposals (Buzby et al., 1996).
2
This methodology consid-
ers two components of the costs of foodborne illness:
lifetime medical costs and lost productivity (e.g., forgone
earnings). This estimate is a partial measure of society’s
opportunity cost; if foodborne illnesses were reduced, these
resources could be reallocated for other uses.
Medical costs were estimated for physician and hospital
services, supplies, medications, and special procedures
unique to treating each foodborne illness. Medical costs
reflect the number of days/treatments of a medical
service, the average cost per service, and the number of
patients receiving such service.
Productivity losses occur when there is a reduction or
cessation of work due to premature mortality and morbid-
ity. Although most people with foodborne illnesses miss
only a day or so of work, some die or contract such
physical complications that they never return to work or
regain only a portion of their pre-illness productivity. ERS
used the Bureau of Labor Statistics’ (BLS) usual weekly
earnings for full-time and part-time wage and salary
earners to calculate the lost productivity for those who
missed some work because of foodborne illness.
Estimating productivity losses for illness-related death
and permanent disability required selecting an appropri-
ate proxy. We used estimates of the value of a statisti-
cal life (VOSL) from the literature that encompass more
than just forgone earnings. Because there is no univer-
sally accepted method to estimate the VOSL (Cropper
and Oates, 1992; Hayes et al., 1995; Randall, 1993;
Smith, 1992; Viscusi, 1992),
3
COI analysis frequently
relies on VOSL estimates from other studies, which may
use a willingness-to-pay (WTP) approach, a human-
capital approach, or a hybrid of these two approaches.
Our COI analysis incorporated conservative VOSL
estimates developed using Landefeld and Seskin’s (LS)
(1982) human capital/WTP hybrid approach. The LS
approach generates the present value of expected-
lifetime after-tax income and housekeeping services at a
3-percent real rate of return, adjusted for an annual 1-
percent increase in labor productivity and a risk-aversion
factor of 1.6.
4
The LS value of a statistical life lost is:
where T = remaining lifetime, t = a particular year, Y
t
=
after-tax income including labor and nonlabor income, r =
household’s opportunity cost of investing in risk-reducing
activities, and
α
= risk-aversion factor. LS VOSL esti-
mates were averaged across gender, interpolated
between LS’s 4-year age groups, and updated to 1995
dollars ($15,000-$1,979,000, depending on age).
The LS VOSL estimates are low compared with VOSL
estimates based on the risk premium in labor markets, a
willingness-to-accept measure, which theory tells us
mirrors WTP.
5
Viscusi (1993) summarized the results of
24 principal wage-risk studies and suggested that most
of the implied VOSL estimates ranged between $3 and
$7 million in 1990 dollars ($3.6-$8.4 million in 1995
dollars).
6
Other regulatory agencies use Viscusi’s VOSL
estimates. The Consumer Product Safety Commission
uses Viscusi’s range and/or a $5-million VOSL in its
analysis (Dworkin, personal communication); the Envi-
ronmental Protection Agency (EPA) uses Viscusi’s range
in estimating the benefits of the Clean Air Act; and FDA
used $5 million in its evaluation of seafood HACCP.
Baseline: Costs of Foodborne Illnesses
The benefits of pathogen reduction are the changes in
foodborne illness costs. Therefore, we need a baseline
of total foodborne illness costs in order to measure
benefits. Total costs of foodborne illness have been
estimated by Buzby and Roberts (1996) in 1995 dollars
7
for six major bacteria (
Campylobacter jejuni or coli,
Clostridium perfringens, E. coli O157:H7, Listeria
monocytogenes, Salmonella, and Staphylococcus
aureus), and one parasite (Toxoplasma gondii)
8
. These
estimates are based on the estimated numbers of
illnesses and deaths reported in table 1. For each of
these pathogens, the estimated medical costs and
productivity losses have been calculated for all foodborne
sources. These estimates are presented as a range,
reflecting the fact that there are low and high estimates
(1 -
r)
t
Y
t
t = 0
T
VOSL =
[
∑
]
α
2
Desirable features of the COI method include its use of existing
and relevant data and its flexibility to perform sensitivity analysis on
estimated total cost to changes in cost subcomponents and disease
severity categories of affected individuals.
3
Four dimensions in valuing life are the duration of life, future
versus present life, life in terms of social or economic productivity, and
the relation of efficiency (cost-effectiveness) to equity.
4
The LS method extends previous work by Rice (1966) by
defining income more broadly and including the risk-aversion factor,
based on the ratio of life-insurance premium payments to life insur-
ance-loss payments.
5
In essence, these values represent what employed people
would pay to reduce the risks generating each additional death.
6
One weakness is that these studies have much better data,
and
more usable estimates, for mortality risks than they do for
morbidity risks (i.e., risk of temporary or long-term illness).
7
Note that the COI estimates for the bacteria in the HACCP final
rule (Federal Register, July 25, 1996) were in 1993 dollars, and were
documented in Buzby et al. (1996).
8
Estimates of illness cases and deaths related to
Toxoplasma
gondii are not included in our analysis of the HACCP proposal.
Toxoplasma is a parasite found within the muscle tissue of animals,
and is not subject to control through HACCP plans as are bacteria.
11
Economic Research Service/USDA
An Economic Assessment of Food Safety Regulations
for the numbers of diseases and deaths in some cases.
Table 3 reports the COI estimates based on two calcula-
tions: one using the Landefeld and Seskin approach to
valuing lost productivity due to premature death or
permanent disability, the other using the value of $5
million per statistical life. Finally, table 3 reports the
percentage shares of annual medical costs and produc-
tivity losses attributable to meat and poultry sources
alone (which are, of course, the target of HACCP regula-
tions).
9
Benefit Estimation
Obviously, there is no single correct estimate of the
benefits of HACCP; the benefits estimates depend on
assumptions made (as outlined above). In our analysis,
we chose several different combinations of assumptions
about effectiveness, discount rates, and valuation
methodology. We started with the original FSIS assump-
tions of 90 percent effectiveness, a 7-percent discount
rate, and Landefeld and Seskin VOSL methodology in
the cost-of-illness calculations. Next, we considered
several alternative scenarios: one yielding a smaller set
of benefits estimates, several mid-range estimates, and a
final set of assumptions that yielded the greatest esti-
mate of the benefits of pathogen reduction associated
with HACCP (tables 4 and 5).
As expected, the benefits estimates varied widely, from
$1.9 billion to $171.8 billion. No matter what the as-
sumptions, though, reducing pathogens through imple-
menting HACCP (even at low effectiveness rates) can be
expected to generate considerable social savings in
terms of lower human illness costs associated with
foodborne pathogens. However, a complete economic
assessment requires a consideration of the costs of
HACCP, and how they compare with the expected
benefits.
Dostları ilə paylaş: